Yee Keat Cheah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yee Keat Cheah has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Chuin-Hen Liew
Department of Pediatrics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
1 shared publication - David Chun-Ern Ng
Hospital Tuanku Ja'afar Seremban Negeri Sembilan Malaysia
1 shared publication Debashini A/P Chandirasekharan
Department of Pediatrics Hospital Tuanku Ja'afar Seremban Seremban Malaysia
1 shared publication- Kah Kee Tan
UCSI Medical School, Faculty of Medicine and Health Sciences, UCSI University , 71010 Port Dickson, Negeri Sembilan, Malaysia
1 shared publication - Ling Chin
Department of Pediatrics Hospital Tuanku Ja'afar Seremban Seremban Malaysia
1 shared publication Munzir Bin Jamil
Department of Pediatrics Hospital Tuanku Ja'afar Seremban Seremban Malaysia
1 shared publication
Latest Publications
- 1 January 2023
- Published by Wiley in Pediatrics International
- Vol. 65 (1) , e15565
Clinical characteristics of COVID‐19 in hospitalized young infants and risk factors for disease severity
Background: This study aimed to describe the clinical characteristics and severity of young infants hospitalized with COVID‐19 and study the relationship between breastfeeding and maternal COVID‐19 vaccination on the severity of COVID‐19.Methods: A retrospective, observational study was performed among infants aged 6 months and below hospitalized for COVID‐19 in a tertiary state hospital in Malaysia between February 1 and April 30, 2022. The primary outcome was “serious disease,” defined as pneumonia requiring respiratory support or dehydration with warning signs. Multivariate logistic regression was used to determine independent predictors for serious disease.Results: A total of 102 infants were included in the study; 53.9% were males with a median age of 11 weeks (interquartile range: 5–20 weeks). Sixteen patients (15.7%) had pre‐existing comorbidities, including preterm birth. Fever was the most common presenting symptom (82.4%), followed by cough (53.9%), and rhinorrhea (31.4%). Forty‐one infants (40.2%) presented with serious disease, warranting either respiratory support or intravenous fluid therapy for dehydration. Recent maternal COVID‐19 vaccination was associated with a reduced risk of serious disease on univariate analysis but was not significant after multivariate adjustment (adjusted odds ratio [aOR] 0.39; 95% CI: 0.14–1.11; p = 0.08). Exclusive breastfeeding was protective against serious COVID‐19 in young infants, independent of other confounding factors (aOR 0.21, 95% CI: 0.06–0.71; p = 0.01).Conclusion: COVID‐19 is a serious disease with non‐specific clinical manifestations in young infants. Exclusive breastfeeding could play an important protective role.
- 1 January 2023
- Published by Wiley in Pediatrics International
- Vol. 65 (1) , e15565
Clinical characteristics of COVID‐19 in hospitalized young infants and risk factors for disease severity
Background: This study aimed to describe the clinical characteristics and severity of young infants hospitalized with COVID‐19 and study the relationship between breastfeeding and maternal COVID‐19 vaccination on the severity of COVID‐19.Methods: A retrospective, observational study was performed among infants aged 6 months and below hospitalized for COVID‐19 in a tertiary state hospital in Malaysia between February 1 and April 30, 2022. The primary outcome was “serious disease,” defined as pneumonia requiring respiratory support or dehydration with warning signs. Multivariate logistic regression was used to determine independent predictors for serious disease.Results: A total of 102 infants were included in the study; 53.9% were males with a median age of 11 weeks (interquartile range: 5–20 weeks). Sixteen patients (15.7%) had pre‐existing comorbidities, including preterm birth. Fever was the most common presenting symptom (82.4%), followed by cough (53.9%), and rhinorrhea (31.4%). Forty‐one infants (40.2%) presented with serious disease, warranting either respiratory support or intravenous fluid therapy for dehydration. Recent maternal COVID‐19 vaccination was associated with a reduced risk of serious disease on univariate analysis but was not significant after multivariate adjustment (adjusted odds ratio [aOR] 0.39; 95% CI: 0.14–1.11; p = 0.08). Exclusive breastfeeding was protective against serious COVID‐19 in young infants, independent of other confounding factors (aOR 0.21, 95% CI: 0.06–0.71; p = 0.01).Conclusion: COVID‐19 is a serious disease with non‐specific clinical manifestations in young infants. Exclusive breastfeeding could play an important protective role.